Cited by

• The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

  Zhang HL, Wu J, Zhu J. Zhang HL, et al. J Biomed Biotechnol. 2010;2010:357412. doi: 10.1155/2010/357412. Epub 2010 Feb 16. J Biomed Biotechnol. 2010. PMID: 20182542 Free PMC article. Review.
• Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.

  Stienekemeier M, Falk K, Rötzschke O, Weishaupt A, Schneider C, Toyka KV, Gold R, Strominger JL. Stienekemeier M, et al. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13872-7. doi: 10.1073/pnas.241504598. Proc Natl Acad Sci U S A. 2001. PMID: 11717443 Free PMC article.
• Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.

  Marsh EA, Hirst CL, Llewelyn JG, Cossburn MD, Reilly MM, Krishnan A, Doran M, Ryan AM, Coles AJ, Jones JL, Robertson NP. Marsh EA, et al. J Neurol. 2010 Jun;257(6):913-9. doi: 10.1007/s00415-009-5437-3. Epub 2010 Jan 6. J Neurol. 2010. PMID: 20049473 Clinical Trial.
• Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

  Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ. Goodyear CS, et al. J Clin Invest. 1999 Sep;104(6):697-708. doi: 10.1172/JCI6837. J Clin Invest. 1999. PMID: 10491405 Free PMC article.
• Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis.

  Zhang Z, Fauser U, Schluesener HJ. Zhang Z, et al. J Cell Mol Med. 2007 Jan-Feb;11(1):111-9. doi: 10.1111/j.1582-4934.2007.00004.x. J Cell Mol Med. 2007. PMID: 17367505 Free PMC article.